ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

First-Line Ipatasertib, Atezolizumab, and Taxane Triplet for Metastatic Triple-Negative Breast Cancer: Clinical and Biomarker Results.

Peter Schmid et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.